Zimlovisertib

SI-1389

Zimlovisertib, >98% (HPLC)

CAS No. : [1817626-54-2]

MDL No. : MFCD30343869

Synonyms : PF-06650833

IUPAC Name : 1-(((2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
10MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
25MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
50MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
100MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
250MG	Request A Quote		Back Order	Estimated to ship on 01 November 2026
Note: Zimlovisertib is not in stock but can be available through custom synthesis. The estimated lead-time is 8-10 weeks. The product will be characterized by NMR and Mass analysis. Purity (HPLC) is usually >98%. COA, QC data and SDS will be provided along with the product. For information on pricing and availability please contact us at sales@syninnova.com or Request A Quote. We respond promptly. Thank You!

Applications : Zimlovisertib is a potent, selective and orally active inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4). It is used to treat diseases such as rheumatoid arthritis, lupus, and lymphomas.

References : Lee K. L. et al.: J. Med. Chem., 60(13), 5521-5542, 2017; Seganish W. M. Expert Opin Ther Pat., 26(8), 917-932, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.